InsiderTrades

Form 4 for DLB Dolby Laboratories, Inc.

Accepted 2023-07-14 00:00:00 ET · period of report 2023-07-12 · accession 0001209191-23-042270 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-14 2023-07-12 DLB SHERMAN MARK ANDREW EVP, Gen. Counsel, Sec M - OptEx $62.32 +21.0K 77.7K +37% +$1.31M
D 2023-07-14 2023-07-12 DLB SHERMAN MARK ANDREW EVP, Gen. Counsel, Sec S - Sale+OE $89.00 -21.0K 56.7K -27% -$1.87M
D 2023-07-14 2023-07-12 DLB SHERMAN MARK ANDREW EVP, Gen. Counsel, Sec M - OptEx $0.00 -21.0K 1,998 -91% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-07-12 M A 21,000 $62.32 77,730 D — — (F2) Shares include 356 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023. (F1) Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
2 Common Class A Common Stock 2023-07-12 S D 21,000 $89.00 56,730 D — — (F1) Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
3 Derivative Employee Stock Option (right to buy) 2023-07-12 M D 21,000 $0.00 1,998 D $62.32 · — to 2024-12-15 21,000 Class A Common Stock (F3) This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.